There’s a lot of concern and confusion right now about the new #sarscov2 variant identified in UK. I’ve spent today and yesterday talking to a dozen people working on this. My story is here: sciencemag.org/news/2020/12/m…
Thread to come (may be long and slow)
There are a ton of things to explain, dozens of questions to discuss and I won’t be able to cover more than a tiny part here now. So three general things up front:
1. Expect more threads and stories on this from me
2. A lot of scientists are working on this. You can follow @firefoxx66, @arambaut, @K_G_Andersen, @GuptaR_lab, @pathogenomenick, @EvolveDotZoo, @jbloom_lab, @Tuliodna for starters.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna 3. This is a really complex topic. There are no easy or fast answers, so be wary of anyone who pretends to have them.
It also means a lot of decisions will have to be made and are being made with considerable uncertainty. That is just the way it is I’m afraid.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna Now to the UK variant:
UK scientists in @CovidGenomicsUK have been following changes in this virus more closely than anyone else. In December they looked at viruses from a surge in cases around Kent and found something very weird:
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK Half the cases seemed to be the same variant (you expect more of a mix). And that variant seemed very distant from the other viruses when you plotted their relationships: There were 17 mutations that led to changes in the make-up of proteins (and some more that didn’t).
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK Amongst those mutations were two of particular interest:
1. N501Y: previously shown to increase how tightly spike binds to ACE2, the virus' entry point into human cells. And @Tuliodna had reported worries that virus with this mutation appeared to be spreading fast in South Africa
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK 2. 69-70del: a deletion of two amino acids in spike. This mutation had been found in virus from an immunocompromised patient who later died. Virus with the mutation (and another) appeared to elude the antibodies in convalescent plasma given to the patient. (work by @GuptaR_lab)
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK It is important to remember that we are dealing with a really complex problem here: A virus competing with other viruses while being attacked by an immune system in a complex human body. What you see in a petri dish does not really tell you what happens in a patient.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK And in genomics, just as in journalism, context matters. A mutation may lead to one thing alone but to something else when it comes on the background of other mutations. That is another layer of complexity.
So seeing these mutations in a virus alone tells you little.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK But the scientists also saw this particular UK variant increasing in frequency in the south east of England quite rapidly.
That could just be chance, a series of super spreading events for instance that just happen to be with this virus. Or something else.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK This summer, for instance, another variant B.1.177 (I know, 🙄) seemed to spread across Europe rapidly. Researchers thought it might transmit better. But it probably just happened to be the strain circulating in Spain where many tourists were that then carried it back home.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK The difference now though is that there is already a lot of virus spreading in the UK, so it seems less likely that this kind of thing could explain why the new variant appears to be taking over. But still, as @firefoxx66 told me: Beware of early data, it can be tricky.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK The point is that taken together this is concerning: the signs we have of some mutations possibly changing the virus in a meaningful way AND the rapid spread of the variant carrying these mutations.
On a very basic level this is why scientists are more worried this time around.
@firefoxx66 @arambaut @K_G_Andersen @GuptaR_lab @pathogenomenick @EvolveDotZoo @jbloom_lab @Tuliodna @CovidGenomicsUK The other worry, of course, is how the virus acquired all these mutations so fast. And what the implications are for vaccines.
I’ll revisit this tomorrow. It’s late and I’m exhausted. Just wanted to explain why we should take seriously concerns that this variant spreads faster.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

21 Dec
It’s becoming clearer that one main hypothesis that scientists are looking at with B.1.1.7 is whether its advantage could be that it is better at infecting children. There are a TON of caveats, but this is one possibility that is being explored.
The idea is very simple: #SARSCoV2 appears to be a bit worse at infecting children than adults. If the mutations in B.1.1.7 allow this variant to bind more tightly to the ACE2 receptor on human cells that could essentially make it as good at infecting children as adults.
Like I said a TON of caveats. Maybe most importantly: the UK had a lockdown while schools were kept open, so you would expect the epidemic to shift more to children anyway and that of course can make it look like there is something going on with this variant in children.
Read 4 tweets
19 Dec
“We urge governments throughout Europe to agree on clearly formulated common goals, coordinate their efforts, develop regionally adapted strategies to reach the goals, and thereby work resolutely towards low case numbers”, @CiesekSandra, @ViolaPriesemann and others in @TheLancet
The lack of a European strategy is something scientists and public health experts have pointed out again and again and it’s good to see it clearly formulated by a group of prominent researchers thelancet.com/journals/lance…
The authors also give a good, succinct summary of arguments for going for low #covid19 case numbers:
1. saving lives
2. saving the economy
3. control is more effective
4. makes TTI feasible
5. natural acquired herd immunity is not an option
6. no need for rapid policy changes
Read 4 tweets
19 Dec
Meine Kollegen vom @pandemiapodcast und ich haben viele Fragen bekommen in den vergangenen Wochen zu den neuen Impstoffen, zu ihrer schnellen Entwicklung, ihrer Sicherheit, zu Impfbereitschaft und Impfpflicht. Wir wollten das natürlich aufnehmen.
@pandemiapodcast Die neue Folge ist darum ein etwas wilder Ritt querfeldein und wir binden zusammen, worüber wir in den ersten Folgen der zweiten Staffel gesprochen haben: Impfstoffe, Pocken, Masern und eben #SARSCoV2. Die Folge gibt es hier: viertausendhertz.de/pan16/
Als Nächstes dann Gelbfieber!
@pandemiapodcast Vielen lieben Dank an @florian_krammer, @CorneliaBetsch, @Karl_Lauterbach, @NatalieGrams und Sidney Chalhoub, die sich alle viel Zeit genommen haben, um mit uns für die Folge zu sprechen.
Read 4 tweets
18 Dec
Global vaccine news: COVAX says deals are in place to access nearly 2 billion doses of #covid19 vaccine. "For the vast majority of these deals, COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available”
The new deals include:
- an advance purchase agreement with AstraZeneca for 170 million doses of the AstraZeneca/Oxford candidate
- a memorandum of understanding (MoU) with Johnson & Johnson for 500 million doses of the Janssen candidate (investigated as single dose vaccine)
That’s on top of:
- agreement with Serum Institute of India for 200 million doses (plus option for 900 million more doses) of either AZ or Novavax vaccine
- statement of intent for 200 million doses of Sanofi/GSK vaccine candidate
Read 12 tweets
18 Dec
Science asked me to -briefly- reflect on what happened in 2020. So, a thread on this year in science, the breakthroughs and breakdowns and where my head is at at the end of this difficult year.

Story is here:
vis.sciencemag.org/breakthrough20…
First, read @sciencecohen's beautiful, personal story on the vaccines:

“I can stop worrying about my mom dying alone in an intensive care unit, away from all who love her. And she can stop asking whether I’ll let her play mahjong with the girls”

vis.sciencemag.org/breakthrough20…
@sciencecohen The rapid development of efficacious #covid19 vaccines was clearly the science breakthrough of the year. But what about all the rest that went on in #covid19 science? My story is labeled “breakdown”, but the picture is complicated.
Read 18 tweets
17 Dec
Expected, but still good #covid19 vaccine news for Europe: @EMA_News has now moved up the likely date for Moderna vaccine as well. Meeting now scheduled for January 6 instead of January 12. Means vaccination with second vaccine likely to start a week earlier than thought in EU.
@EMA_News "Today, ahead of schedule, the company has submitted the last outstanding data package needed for the assessment of the application. This contains information that is specific to the manufacturing of the vaccine for the EU market“, says EMA press release.
@EMA_News "The number of infections is increasing across Europe and we are aware of the huge responsibility we have to get a vaccine to the market as quickly as is feasible, whilst maintaining the robustness of our scientific review”, EMA head Emer Cooke says in the press release.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!